51 related articles for article (PubMed ID: 22521528)
1. PET/CT scanning guided intensity-modulated radiotherapy in treatment of recurrent ovarian cancer.
Du XL; Jiang T; Sheng XG; Li QS; Wang C; Yu H
Eur J Radiol; 2012 Nov; 81(11):3551-6. PubMed ID: 22521528
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic value of PET/CT is similar to that of conventional MRI and even better for detecting small peritoneal implants in patients with recurrent ovarian cancer.
Sanli Y; Turkmen C; Bakir B; Iyibozkurt C; Ozel S; Has D; Yilmaz E; Topuz S; Yavuz E; Unal SN; Mudun A
Nucl Med Commun; 2012 May; 33(5):509-15. PubMed ID: 22357440
[TBL] [Abstract][Full Text] [Related]
3. Low-dose non-enhanced CT versus full-dose contrast-enhanced CT in integrated PET/CT scans for diagnosing ovarian cancer recurrence.
Kitajima K; Ueno Y; Suzuki K; Kita M; Ebina Y; Yamada H; Senda M; Maeda T; Sugimura K
Eur J Radiol; 2012 Nov; 81(11):3557-62. PubMed ID: 22534465
[TBL] [Abstract][Full Text] [Related]
4. Predictive role of post-treatment [18F]FDG PET/CT in patients with uterine cervical cancer.
Chung HH; Kim JW; Kang KW; Park NH; Song YS; Chung JK; Kang SB
Eur J Radiol; 2012 Aug; 81(8):e817-22. PubMed ID: 22595504
[TBL] [Abstract][Full Text] [Related]
5. Initial experience using intensity-modulated radiotherapy for recurrent nasopharyngeal carcinoma.
Lu TX; Mai WY; Teh BS; Zhao C; Han F; Huang Y; Deng XW; Lu LX; Huang SM; Zeng ZF; Lin CG; Lu HH; Chiu JK; Carpenter LS; Grant WH; Woo SY; Cui NJ; Butler EB
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):682-7. PubMed ID: 14967420
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of integrated whole-body PET/CT in the detection of recurrent ovarian cancer.
Hauth EA; Antoch G; Stattaus J; Kuehl H; Veit P; Bockisch A; Kimmig R; Forsting M
Eur J Radiol; 2005 Nov; 56(2):263-8. PubMed ID: 16233894
[TBL] [Abstract][Full Text] [Related]
7. Deformable registration of preoperative PET/CT with postoperative radiation therapy planning CT in head and neck cancer.
Kovalchuk N; Jalisi S; Subramaniam RM; Truong MT
Radiographics; 2012; 32(5):1329-41. PubMed ID: 22977021
[TBL] [Abstract][Full Text] [Related]
8. Value of dual time point F-18 FDG-PET/CT imaging for the evaluation of prognosis and risk factors for recurrence in patients with stage I non-small cell lung cancer treated with stereotactic body radiation therapy.
Satoh Y; Nambu A; Onishi H; Sawada E; Tominaga L; Kuriyama K; Komiyama T; Marino K; Aoki S; Araya M; Saito R; Maehata Y; Oguri M; Araki T
Eur J Radiol; 2012 Nov; 81(11):3530-4. PubMed ID: 22178287
[TBL] [Abstract][Full Text] [Related]
9. Impact of FDG PET/CT on delineation of the gross tumor volume for radiation planning in non-small-cell lung cancer.
Spratt DE; Diaz R; McElmurray J; Csiki I; Duggan D; Lu B; Delbeke D
Clin Nucl Med; 2010 Apr; 35(4):237-43. PubMed ID: 20305410
[TBL] [Abstract][Full Text] [Related]
10. Integration of FDG-PET/CT into external beam radiation therapy planning: technical aspects and recommendations on methodological approaches.
Thorwarth D; Beyer T; Boellaard R; de Ruysscher D; Grgic A; Lee JA; Pietrzyk U; Sattler B; Schaefer A; van Elmpt W; Vogel W; Oyen WJ; Nestle U
Nuklearmedizin; 2012; 51(4):140-53. PubMed ID: 22473130
[TBL] [Abstract][Full Text] [Related]
11. Predictive value of PET-CT imaging versus AGO-scoring in patients planned for cytoreductive surgery in recurrent ovarian cancer.
Lenhard SM; Burges A; Johnson TR; Kirschenhofer A; Bruns C; Linke R; Friese K
Eur J Obstet Gynecol Reprod Biol; 2008 Oct; 140(2):263-8. PubMed ID: 18614272
[TBL] [Abstract][Full Text] [Related]
12. Combined positron emission tomography-computed tomography and tumor markers for detecting recurrent ovarian cancer.
Pan HS; Lee SL; Huang LW; Chen YK
Arch Gynecol Obstet; 2011 Feb; 283(2):335-41. PubMed ID: 20221620
[TBL] [Abstract][Full Text] [Related]
13. The impact of PET and PET/CT on treatment planning and prognosis of patients with NSCLC treated with radiation therapy.
Nawara C; Rendl G; Wurstbauer K; Lackner B; Rettenbacher L; Datz L; Studnicka M; Sedlmayer F; Pirich C
Q J Nucl Med Mol Imaging; 2012 Apr; 56(2):191-201. PubMed ID: 22402822
[TBL] [Abstract][Full Text] [Related]
14. PET/CT staging followed by Intensity-Modulated Radiotherapy (IMRT) improves treatment outcome of locally advanced pharyngeal carcinoma: a matched-pair comparison.
Rothschild S; Studer G; Seifert B; Huguenin P; Glanzmann C; Davis JB; Lütolf UM; Hany TF; Ciernik IF
Radiat Oncol; 2007 Jun; 2():22. PubMed ID: 17559684
[TBL] [Abstract][Full Text] [Related]
15. The value of image-guided intensity-modulated radiotherapy in challenging clinical settings.
Treece SJ; Mukesh M; Rimmer YL; Tudor SJ; Dean JC; Benson RJ; Gregory DL; Horan G; Jefferies SJ; Russell SG; Williams MV; Wilson CB; Burnet NG
Br J Radiol; 2013 Jan; 86(1021):20120278. PubMed ID: 23255544
[TBL] [Abstract][Full Text] [Related]
16.
Dang YZ; Li X; Ma YX; Li XL; Yang T; Lu WL; Huang SG
Oncol Lett; 2019 Jan; 17(1):149-158. PubMed ID: 30655750
[TBL] [Abstract][Full Text] [Related]
17. Survival effect of pre-RT PET-CT on cervical cancer: Image-guided intensity-modulated radiation therapy era.
Su CH; Chen WM; Chen M; Shia BC; Wu SY
Front Oncol; 2023; 13():1012491. PubMed ID: 36798817
[TBL] [Abstract][Full Text] [Related]
18. Combined PET/CT for detecting recurrent ovarian cancer limited to retroperitoneal lymph nodes.
Markman M
Gynecol Oncol; 2006 Jun; 101(3):550-1; author reply 551-2. PubMed ID: 16540155
[No Abstract] [Full Text] [Related]
19. Image-Guided IMRT.
Low D
Med Phys; 2006 Nov; 33(11):4450. PubMed ID: 28523684
[TBL] [Abstract][Full Text] [Related]
20. The technical design and concept of a PET/CT linac for biology-guided radiotherapy.
Oderinde OM; Shirvani SM; Olcott PD; Kuduvalli G; Mazin S; Larkin D
Clin Transl Radiat Oncol; 2021 Jul; 29():106-112. PubMed ID: 34258399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
